An update on childhood and adolescent vaccines.
In 2008, the recommendations for vaccines in children and adolescents changed substantially. The Advisory Committee on Immunization Practices expanded the routine use of influenza vaccines. New recommendations also addressed the newly licensed rotavirus vaccine. Furthermore, the Advisory Committee on Immunization Practices addressed the use of the meningococcal conjugate vaccine in children aged 2 to 10 years who are at high risk of that disease. Finally, the Food and Drug Administration and the Centers for Disease Control and Prevention reviewed the safety data collected about the human papillomavirus vaccine since its licensure and reaffirmed their recommendations for its use. This article discusses some of the important changes that should be of concern to the practitioner.
Jacobson
Robert M
RM
Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA. jacobson.robert@mayo.edu
D000293:Adolescent; D002487:Centers for Disease Control and Prevention, U.S.; D002648:Child; D002675:Child, Preschool; D006801:Humans; D017589:Immunization Programs / Q000592:standards; D007223:Infant; D007231:Infant, Newborn; D007252:Influenza Vaccines / Q000008:administration & dosage; D022401:Meningococcal Vaccines / Q000008:administration & dosage; D053918:Papillomavirus Vaccines / Q000008:administration & dosage; D022243:Rotavirus Vaccines / Q000008:administration & dosage; D012449:Safety; D014481:United States; D014611:Vaccination / Q000592:standards*
D007252:Influenza Vaccines; D022401:Meningococcal Vaccines; D053918:Papillomavirus Vaccines; D022243:Rotavirus Vaccines